Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay

Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay

COVID-19 (Coronavirus Disease 2019) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus-2) continues to pose an international public health threat and thus far, has resulted in greater than 6.4 million deaths worldwide. Vaccines are critical tools to limit COVID-19 spread, but antivi...

Full description

Bibliographic Details
Main Authors: Timsy Uppal, Kai Tuffo, Svetlana Khaiboullina, Sivani Reganti, Mark Pandori, Subhash C. Verma
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Cell Insight
Subjects:
SARS-CoV-2
COVID-19
RdRp
Antivirals
Dasabuvir
Ribavirin
Online Access:http://www.sciencedirect.com/science/article/pii/S2772892722000438

Internet

http://www.sciencedirect.com/science/article/pii/S2772892722000438

Similar Items